1. Home
  2. SEDG vs NNNN Comparison

SEDG vs NNNN Comparison

Compare SEDG & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SolarEdge Technologies Inc.

SEDG

SolarEdge Technologies Inc.

HOLD

Current Price

$35.06

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$21.09

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEDG
NNNN
Founded
2006
2021
Country
Israel
Germany
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2015
2025

Fundamental Metrics

Financial Performance
Metric
SEDG
NNNN
Price
$35.06
$21.09
Analyst Decision
Hold
Analyst Count
20
0
Target Price
$26.86
N/A
AVG Volume (30 Days)
2.6M
37.3K
Earning Date
02-18-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.06
Revenue
$1,045,303,000.00
$6,920,153.00
Revenue This Year
$33.56
N/A
Revenue Next Year
$15.45
N/A
P/E Ratio
N/A
$386.55
Revenue Growth
2.35
N/A
52 Week Low
$11.00
$5.18
52 Week High
$48.60
$55.65

Technical Indicators

Market Signals
Indicator
SEDG
NNNN
Relative Strength Index (RSI) 60.17 35.63
Support Level $33.68 $28.61
Resistance Level $36.00 $31.52
Average True Range (ATR) 2.08 4.86
MACD 0.31 -1.64
Stochastic Oscillator 76.72 10.10

Price Performance

Historical Comparison
SEDG
NNNN

About SEDG SolarEdge Technologies Inc.

SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: